RiboGenyX
1 known investors
Find your way into RiboGenyX
Sign up to see every warm intro you have to RiboGenyX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RiboGenyX team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ribogenyx develops first-in-class therapeutic enhancers of translational fidelity, targeting mRNA translation processes for precision medicine. Its focus is on age-related diseases and mechanisms of stress resilience mediated by mRNA translation.
Founders & leadership
Investors · 1
Frequently asked questions
- What does RiboGenyX do?
- Ribogenyx develops first-in-class therapeutic enhancers of translational fidelity, targeting mRNA translation processes for precision medicine. Its focus is on age-related diseases and mechanisms of stress resilience mediated by mRNA translation.
- Who founded RiboGenyX?
- RiboGenyX was founded by Angelos, Maxime.
- Who are RiboGenyX's investors?
- RiboGenyX's investors include Fifty Years.

